All News

    First Patient Dosed With KSQ-004EX In Solid Tumor Clinical Trial

    April 12th 2025, 2:00pm

    Article

    KSQ-004EX is being evaluated in solid tumors including melanoma, non-small cell lung, head and neck, colorectal, pancreatic and cervical cancer.

    Imdelltra May Improve Survival in Small Cell Lung Cancer

    April 11th 2025, 9:00pm

    Article

    Imdelltra is associated with improvement in overall survival compared to local standard-of-care chemotherapy among patients with small cell lung cancer.

    A Kidney Cancer Advocate Shares Advice for Newly Diagnosed Patients

    April 11th 2025, 8:00pm

    Video

    Some cancer statistics may reflect 'backwards-looking data', making it important to stay up to date on reliable information and happenings in the space.

    Knowing the Signs to Detect and Treat Testicular Cancer Early

    April 11th 2025, 7:00pm

    Article

    Testicular cancer is rare but highly curable, especially with early detection; treatment varies by stage, and follow-up care supports long-term health.

    Spring Forward: How I Stay Grounded and Hopeful with Lynch Syndrome

    April 11th 2025, 5:00pm

    Article

    Living with Lynch isn't easy, but it's not all doom and gloom. It's a call to live deliberately.

    What Role May ctDNA Have in Melanoma Management?

    April 11th 2025, 1:00pm

    Article

    CURE spoke with Dr. Michael K. Wong and Dr. Diwakar Davar about the use of ctDNA for patients with melanoma, and where the field may be headed.

    An Expert Breaks Down Lymphedema Following Cancer Care

    April 10th 2025, 9:00pm

    Video

    Dr. Sheri Yolanda Prentiss discusses the importance of seeking early intervention to detect lymphedema following cancer care.

    Melanoma Taught Me Faith, Gratitude and That Nothing Is Permanent

    April 10th 2025, 8:00pm

    Article

    I was diagnosed with stage 3 melanoma at 31, faced recurrence and now share my journey to raise awareness, stay hopeful and trust in God’s plan.

    FDA Approves Avastin Biosimilar Jobevne Across Several Cancer Types

    April 10th 2025, 7:00pm

    Article

    The FDA has approved Jobevne, a biosimilar to Avastin, for IV use in a number of cancer types.

    Managing Cancer Demands With Flexibility and a Strategic Mindset

    April 10th 2025, 5:00pm

    Article

    It isn’t easy having cancer. But like gardening in a harsh climate, survival and growth come from strategies, adaptation, and patience.